博拓生物 Stock: price and insider trades · China
博拓生物: what insiders have been doing
Every trade that managers of 博拓生物 disclose to SSE / SZSE (CSRC) is tracked on this page. The company sits in the Health Care sector. 博拓生物 has had no insider filing for more than a year; the last one goes back to 8 May 2025.
The full history, which starts in 2022, counts no purchases against 4 sales.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 12,000 shares24.7% of flowA股XSHGSSE:173000008931453920
- 6,000 shares12.0% of flowA股XSHGSSE:173000008920685730
- 33,000 shares63.3% of flowA股XSHGSSE:173000008737816030
- 200 shares100.0% of flowA股XSHGSSE:173000005341735680
4 of 4 declarations
About 博拓生物
博拓生物 is a company specializing in the healthcare and pharmaceutical sector, listed on the XSHG market. It focuses on developing innovative biopharmaceutical solutions.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
